Skip to main content
Gut logoLink to Gut
. 1993 Apr;34(4):565–566. doi: 10.1136/gut.34.4.565

Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle?

A Rhodes 1, J B Eastwood 1, S A Smith 1
PMCID: PMC1374323  PMID: 8491409

Abstract

A 72 year old white man developed acute hepatic impairment and renal failure within 24 hours of starting intravenous amiodarone for paroxysmal ventricular tachycardia. After normal initial investigations, there was a noticeable rise in serum transaminases as well as an increase in clotting times, a decrease in renal function and a thrombocytopenia. These changes returned to normal within seven days of withdrawal of the drug without specific treatment, and the patient was later treated with oral amiodarone without any further evidence of hepatotoxicity. Intravenous amiodarone has been implicated in acute hepatic disease on four previous occasions, but it is suggested that polysorbate 80, an organic surfactant added to the intravenous infusion, is a more likely cause of this complication. Similar reactions have been described with polysorbate 80 in association with the 'E-ferol' syndrome in infants. The occurrence of acute hepatic impairment with intravenous amiodarone does not necessarily preclude the use of this drug by mouth.

Full text

PDF
565

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Harris L., McKenna W. J., Rowland E., Holt D. W., Storey G. C., Krikler D. M. Side effects of long-term amiodarone therapy. Circulation. 1983 Jan;67(1):45–51. doi: 10.1161/01.cir.67.1.45. [DOI] [PubMed] [Google Scholar]
  2. Lupon-Rosés J., Simó-Canonge R., Lu-Cortez L., Permanyer-Miralda G., Allende-Monclús H. Probable early acute hepatitis with parenteral amiodarone. Clin Cardiol. 1986 May;9(5):223–225. doi: 10.1002/clc.4960090512. [DOI] [PubMed] [Google Scholar]
  3. McGovern B., Garan H., Kelly E., Ruskin J. N. Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) 1983 Jul 16;287(6386):175–180. doi: 10.1136/bmj.287.6386.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Plomteux G., Heusghem C., Ernould H., Vandeghen N. Long-term hepatic tolerance of amiodarone in the clinic. Eur J Pharmacol. 1969 Dec;8(3):369–376. doi: 10.1016/0014-2999(69)90049-1. [DOI] [PubMed] [Google Scholar]
  5. Pye M., Northcote R. J., Cobbe S. M. Acute hepatitis after parenteral amiodarone administration. Br Heart J. 1988 Jun;59(6):690–691. doi: 10.1136/hrt.59.6.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Stevenson R. N., Nayani T. H., Davies J. R. Acute hepatic dysfunction following parenteral amiodarone administration. Postgrad Med J. 1989 Sep;65(767):707–708. doi: 10.1136/pgmj.65.767.707-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES